LKLaya Krishnan

Laya Krishnan

*This is an algorithmically generated author record based on publicly available information.

Laya Krishnan has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Leveraging artificial intelligence for analysis of the gut microbiome for dementia diagnosis: a scoping review and discussion

    by Laya Krishnan, Gaurie Gunasekaran, Tamanna Dhore, Alexa Lauinger, Vijaya Kolachalama, Suguna Pappu

    Background: Dementia, a multifactorial disease with progressive cognitive decline, has been linked to imbalances in the gut-brain axis. Emerging artificial intelligence tools have augmented the identification of several gastrointestinal biomarkers for differential dementia detection and severity, but current literature lacks a comprehensive review. Aims: This study aims to better quantify the applications of AI in the exploration of the gut microbiome for diagnosis of specific subtypes of dementia. Methods: Primary articles ( n = 896) from any point in time through July 2025 were identified from PubMed, Web of Science, Scopus, and ScienceDirect. Title and abstract screenings filtered articles from 896 to 28 for critical appraisal and review for key bacteria, fungi, and metabolites. Methods adhered to the PRISMA extension for Scoping Reviews (PRISMA-ScR) guidelines. Results: Several studies utilized predictive models including random forests and neural networks to demonstrate alterations in the gut microbiota of Alzheimer’s disease, an increasingly prevalent dementia subtype. These individuals have notably reduced levels of butyrate-producing bacteria, such as Butyrivibrio , Eubacterium , and Faecalibacterium , which contribute to anti-inflammation and gut-barrier maintenance. Increased levels of Odoribacter splanchnicus and Klebsiella pneumoniae, as well as bacteria from generas Bacteroides and Prevotella, which help generate short-chain fatty acids, have been implicated in neuroinflammation; Roseburia inulinivorans negatively correlates with functional ability. Interestingly, superagers also display unique microbiome profiles that seemingly have protective effects linked to superior cognitive resilience. Conclusion: Distinct gut microbial compositions are associated with dementia. Furthermore, elucidating gut-brain interactions and their neurodegenerative implications can identify targets for earlier, synergistic diagnostics. Systematic review registration: https://osf.io/yw2dc/overview .


  • Management Patterns, Outcomes, and Timing Differences in Carpal Tunnel Syndrome Treatment: A Retrospective Review at a Single Institution from 2019-2024

    by Christopher Eduard Lingat, Usama N. Ismail, Gaurang M. Amonkar, Derek S. Anderson, Alexander Chueh, Sajan Goyal, Timothy T. Huang, Justin Kim, Laya P. Krishnan, Tyler B. Nofzinger, et al.

    Background: Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy that may be managed with conservative therapies and/or surgical decompression. Although both strategies are routinely used, limited data exists on how management patterns evolve within individual healthcare systems over time. This study examined trends in CTS treatment utilization, timing to surgery, and patient outcomes over a five-year period. Methods: A retrospective cohort study of adult patients diagnosed with CTS at the Carle Health System between September 1st, 2019 and September 1st, 2024 was conducted. Eligible records were identified through the electronic medical record and manually reviewed. Data collected included non-surgical and surgical treatments used, symptom improvement, follow-up completion, and timing intervals for injections and carpal tunnel release (CTR). Descriptive statistics were generated, and Fisher’s exact and Kruskal-Wallis tests were used to explore annual differences. All inferential analysis were considered exploratory due to small sample size. Results: Of 516 identified patients, 62 met inclusion criteria. Across the study period, the proportion of patients receiving wrist splinting (43-73%) and CTR (43-73%) remained relatively stable, with CTR performed in 60% of patients overall. Management pathway distributions, non-surgical only (27%), surgical only (13%), both (47%), or no treatment (13%), did not differ significantly across years (p >0.05). Among patients receiving injections, 70% reported symptom improvement, while postoperative CTR cure rate was found to be 95%. CTR follow-up was completed in 73% of surgical patients. Median time from diagnosis to injection was 289 days, from diagnosis to CTR was 143 days, and from surgery to follow-up was 13 days, with no significant temporal differences (p>0.05). Conclusions: CTS management patterns at the Carle Health System have remained consistent from 2019-2024, with high rates of surgical success and variable time to intervention. Although sample size and documentation variability were limiting factors, these finding provide a baseline characterization of local practice and highlight opportunities to improve referral efficiency and postoperative follow-up. Larger studies are needed to better define the progression of CTS care trends.

  • Open Access

    A Rare Case of Pyoderma Gangrenosum Pointing to Waldenström Macroglobulinemia

    by Laya Krishnan, Emily Vachon, Anvita Mishra, Dawn McCoy

    Background: Pyoderma gangrenosum (PG) is a rare, noninfectious, truly nongangrenous, autoinflammatory condition marked by neutrophilic dermatosis. It is characterized by the rapid onset of painful, full‐thickness, ulcerative skin lesions with distinctive violaceous and undermined borders. PG is commonly associated with autoimmune and hematologic disorders, namely, inflammatory bowel disease (IBD) and monoclonal gammopathy of undetermined significance (MGUS). However, it has less commonly been reported in association with lymphoplasmacytic lymphoma (LPL) and rarely with its subtype, Waldenström macroglobulinemia (WM). Case Presentation: This case unfolds the story of a 72‐year‐old female patient with a complex medical and primarily cutaneous oncological history, who initially developed painful lesions on her shins suspected to be PG with a superimposed infection. During extensive infectious, rheumatologic, and oncologic workup revealing an IgM monoclonal gammopathy and antibiotic‐resistant infections, her condition quickly deteriorated with altered mental status and eventual cardiopulmonary arrest 2 months after the initial PG diagnosis. Conclusion: This case highlights the importance of close follow‐up after PG identification for unusual underlying malignancies and suggests that even an indolent malignancy like WM can contribute to aggressive clinical decline in this setting.